Adapted from CURRENT Medical Diagnosis & Treatment 2010
Laboratory monitoring & evaluation tool Xpert Pre-installation Checklist
Accessed December 2017
Annex to Selection and use of Ebola in vitro diagnostic assays
African Journal of Laboratory Medicine | Vol 7, No 2 | a770 | 06 December 2018
African Journal of Laboratory Medicine | Vol 7, No 2 | a796 | 06 December 2018
This manual is designed primarily to assist managers of national malaria programmes and national reference laboratory responsible for quality assurance of malaria microscopy control. The information is also applicable to non-governmental organizations and funding agencies investing in quality manage...ment systems for malaria microscopy.
more
This clinical job aid provides health care workers with information on how to collect specimens for early infant diagnosis on dried blood spots, as well as drying and packaging for transport.
DIAGNOSIS, MANAGEMENT OF UNCOMPLICATED AND SEVERE MALARIA
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.
Pour une intervention efficace et efficiente de lutte anti-vectorielle, il est nécessaire de disposer au préalable des informations sur l’écologie, le comportement et la dynamique des populations de vecteurs locaux. Après interventions, il est fondamental d'évaluer l'effet des opérations et... aussi de pouvoir détecter ou prédire les fluctuations inhabituelles des tendances qui peuvent avoir des conséquences significatives sur la maladie.
Pour cette raison, des scientifiques d'institutions de recherche, des programmes nationaux de lutte contre le paludisme et de l'OMS se sont réunis en Juin 2008, à Libreville (Gabon) pour élaborer le premier projet de document intitulé «procédures opérationnelles standardisées (SOP) pour la surveillance des vecteurs dans le cadre de la surveillance intégrée des maladies et la gestion intégrée des vecteurs ». Le Projet de document a été finalisé par deux consultants et envoyé aux 7 pays pilotes pour être testé sur le terrain.
more
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in... detail in order to serve also other pathologies and conditions, like trauma and pneumonia.
Through the definition of "minimum technical requirements", this document is recommended to support decision-making regarding the selection, incorporation, allocation and use of portable X-ray systems and is intended for health care providers, managers of imaging departments, procurement and regulatory agencies, policymakers and planning officers in ministries of health, as well as biomedical engineering professionals, medical physicists, the private health sector, medical device industry and intergovernmental and international agencies.
more
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...n rural areas of low-income countries, making it difficult to identify and treat patients. Additionally, there is controversy about the role, type and duration of anthelmintic, antiinflammatory and antiepileptic drug (AED) treatments for different forms of neurocysticercosis.
These guidelines were developed to assist health-care providers in appropriate, evidence-based management of parenchymal neurocysticercosis. The guidelines do not address other forms of neurocysticercosis and do not include management of extraparenchymal disease (including cysticerci in the cerebral ventricles or subarachnoid space). The aim of the guidance is to improve decision-making to ensure appropriate patient care and to avoid misdiagnoses and inappropriate treatment of patients with neurocysticercosis.
more
Guidelines for diagnosis, acute care and post-COVID-19 follow-up for children and adolescents